New users often try ChatGPT once or twice, get a bland answer, then walk away. Yet the same system that feels underwhelming ...

In her four years at Wellesley, Rodham had witnessed urban riots, the escalation of the war in Vietnam and the murders of the Rev. Martin Luther King Jr. and Robert F. Kennedy. She was in no mood to ...

UMEVO's flagship AI recorder offers 1 year of free unlimited transcription and no forced monthly subscriptions, ...

New AI transcription tool turns screen recordings into searchable text, subtitles, and MP4 transcripts in seconds. Our ...

A Raspberry Pi 5 offline local AI projects has bee nupdated with offline vision and image generation using CR3VL is a 2B-parameter model, expanding local AI skills without cloud services ...

Red flags for generic writing include overwriting, repetitive sentence structures, tired metaphors, clichés (both linguistic and stylistic), and dialogue in which every character sounds the same. Make ...

Imagine finishing a 300-page book during your morning commute — without ever flipping a page. That's no longer a fantasy.

G-Stacker has announced the availability of its digital infrastructure platform designed to automate the development of interconnected Google properties. The software operates as a technical solution ...

VoiceCraft is a token infilling neural codec language model, that achieves state-of-the-art performance on both speech editing and zero-shot text-to-speech (TTS) on in-the-wild data including ...

Abstract: Automatic Speech Recognition (ASR) systems are widely used for speech censoring. Speech Adversarial Example (AE) offers a novel approach to protect speech privacy by forcing ASR to ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...